| 今开：0.0 | 昨收：15.855 |
| 最高：0.0 | 最低：0.0 |
| 涨停价：0.0 | 跌停价：0.0 |
| 总市值：8.586209642E9 |
Mylan(MYL)2020-02-28 05:45
$Mylan(MYL)$ 425 Prospectuses and communications, business combinations Accession Number: 0001193125-20-052796 Act: 34 Size: 35 KB 网页链接查看全文
Mylan(MYL)2020-02-28 05:45
$Mylan(MYL)$ 425 Prospectuses and communications, business combinations Accession Number: 0001193125-20-052818 Act: 34 Size: 17 KB 网页链接查看全文
Mylan(MYL)2020-02-28 05:25
$Mylan(MYL)$ 8-K Current report, items 2.02, 2.05, 8.01, and 9.01 Accession Number: 0001623613-20-000009 Act: 34 Size: 1 MB 网页链接查看全文
Mylan(MYL)2020-02-14 06:15
$Mylan(MYL)$ DEFM14A Definitive proxy statement relating to merger or acquisition Accession Number: 0001193125-20-035762 Act: 34 Size: 9 MB 网页链接查看全文
Mylan(MYL)2020-02-12 20:30
$Mylan(MYL)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001104659-20-017633 Act: 34 Size: 12 KB 网页链接查看全文
Mylan(MYL)2020-02-12 19:26
$Mylan(MYL)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001104659-20-017063 Act: 34 Size: 13 KB 网页链接查看全文
Mylan(MYL)2020-02-10 20:51
$Mylan(MYL)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0000834237-20-008693 Act: 34 Size: 13 KB 网页链接查看全文
Mylan(MYL)2020-02-08 20:46
$Mylan(MYL)$ 内部交易: 2020-02-05,See Remarks,Campbell Paul ,卖出,11611普通股, $23.00查看全文
Mylan(MYL)2020-02-08 07:10
$Mylan(MYL)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000899243-20-003710 Size: 9 KB 网页链接查看全文
诺和诺德就减肥药Ozempic和Wegovy的专利纠纷与迈兰制药达成和解。 诺和诺德就减肥药Ozempic和Wegovy的专利纠纷与迈兰制药达成和解。 网页链接
原标题：迈兰6亿欧元出手收购，全球最大仿制药企却在“沉没”？ 近日，全球制药公司迈兰（Mylan N.V.）（NASDAQ：MYL）宣布达成一项协议，以6.419亿欧元的价格收购南非制药公司Aspen Pharmacare在欧洲的血栓相关知识产权和商... 网页链接
$Mylan(MYL)$ 15-15D Suspension of duty to report [Section 13 and 15(d)] Accession Number: 0001193125-20-304601 Act: 34 Size: 13 KB 网页链接
$Mylan(MYL)$ 8-K Current report, items 1.01, 1.02, 2.01, 2.03, 3.01, 3.03, 5.01, 5.02, and 9.01 Accession Number: 0001193125-20-298224 Act: 34 Size: 831 KB 网页链接
$Mylan(MYL)$ 内部交易: 2020-11-16,Director,Vollebregt Sjoerd S ,期权,9440普通股, $0.00
$Mylan(MYL)$ 内部交易: 2020-11-16,Director,VANDERVEEN RANDALL L ,期权,9440普通股, $0.00
$Mylan(MYL)$ 内部交易: 2020-11-16,Director,Cindrich Robert J ,期权,9440普通股, $0.00
$Mylan(MYL)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000899243-20-031519 Size: 45 KB 网页链接
$Mylan(MYL)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000899243-20-031511 Size: 51 KB 网页链接
$Mylan(MYL)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000899243-20-031512 Size: 25 KB 网页链接
$Mylan(MYL)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000899243-20-031513 Size: 25 KB 网页链接
$Mylan(MYL)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000899243-20-031514 Size: 26 KB 网页链接